Italy (IT)

Streptozotocin, 1982-2022: Forty Years from the FDA's Approval to Treat Pancreatic Neuroendocrine Tumors (2022) Capdevila J, Ducreux M, García Carbonero R, Grande E, Halfdanarson T, Pavel ME, Tafuto S, et al. Journal article, Review article Cytologic scoring of equine exercise-induced pulmonary hemorrhage: Performance of human experts and a deep learning-based algorithm (2022) Bertram CA, Marzahl C, Bartel A, Stayt J, Bonsembiante F, Beeler-Marfisi J, Barton AK, et al. Journal article Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R Study (2022) Girard N, Bar J, Garrido P, Garassino MC, McDonald F, Mornex F, Filippi AR, et al. Journal article MACHINE-LEARNING CLUSTERING METHODS APPLIED TO DETECTION OF NOISE SOURCES IN LOW-SPEED AXIAL FAN (2022) Tieghi L, Becker S, Corsini A, Delibra G, Schoder S, Czwielong F Conference contribution Prostate Adenocarcinoma Grade Group 1: Rationale for Retaining a Cancer Label in the 2022 World Health Organization Classification (2022) Netto GJ, Amin MB, Compérat EM, Gill AJ, Hartmann A, Moch H, Menon S, et al. Journal article Electromyography-Based, Robust Hand Motion Classification Employing Temporal Multi-Channel Vision Transformers (2022) Godoy RV, Lahr GJ, Dwivedi A, Reis TJ, Polegato PH, Becker M, Caurin GA, Liarokapis M Conference contribution MirrorSAR: An HRWS Add-On for Single-Pass Multi-Baseline SAR Interferometry (2022) Mittermayer J, Krieger G, Bojarski A, Zonno M, Villano M, Pinheiro M, Bachmann M, et al. Journal article Prognosis of Patients With Primary Melanoma Stage I and II According to American Joint Committee on Cancer Version 8 Validated in Two Independent Cohorts: Implications for Adjuvant Treatment. (2022) Garbe C, Keim U, Amaral T, Berking C, Eigentler TK, Flatz L, Gesierich A, et al. Journal article Etrolizumab as induction and maintenance therapy in patients with moderately to severely active Crohn's disease (BERGAMOT): a randomised, placebo-controlled, double-blind, phase 3 trial (2022) Sandborn WJ, Panés J, Danese S, Sharafali Z, Hassanali A, Jacob-Moffatt R, Eden C, et al. Journal article THE EMLex DICTIONARY OF LEXICOGRAPHY (EMLexDictoL) (2022) Schierholz SJ, Bielinska M, Domínguez Vázquez MJ, Gouws RH, Nied Curcio M Conference contribution